Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Phase IV Study to Evaluate the Ability of Definity® Enhanced Versus Unenhanced Echocardiography to Improve the Accuracy and Reproducibility of Left Ventricular Ejection Fraction When Compared to Cardiac Magnetic Resonance Imaging

NCT00401687 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.

NCT NCT00401687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00401687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Phase IV Study to Evaluate the Ability of Definity® Enhanced Versus Unenhanced Echocardiography to Improve the Accuracy and Reproducibility of Left Ventricular Ejection Fraction When Compared to Cardiac Magnetic Resonance Imaging
Lead sponsor
Lantheus Medical Imaging
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2006
Completion date
April 30, 2008
Enrollment
131 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular ejection fraction